stockrowGenmab A/S Sponsored ADR
GMAB Healthcare Biotechnology
Genmab A/S Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 19.2% from fiscal 2024.
- Revenue
- +24.9%
- EPS
- −9.26%
- Free cash flow
- −7.69%
Quarter to June 2026, against a year earlier
Follow GMAB
Alert me
Genmab A/S Sponsored ADR (GMAB) Book value per share
Genmab A/S Sponsored ADR's book value per share at the end of fiscal 2025 was 9.4×, up 17.5% from 8.0× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 9.7×. Over the past ten years it has ranged from 1.1× (fiscal 2016) to 9.4× (fiscal 2025) — the current reading is the highest in ten years. Genmab A/S Sponsored ADR ranks 79th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 9.4× | 17.55% |
| FY2024 | 8.0× | 13.88% |
| FY2023 | 7.0× | 18.26% |
| FY2022 | 5.9× | 10.05% |
| FY2021 | 5.4× | 20.15% |
| FY2020 | 4.5× | 34.38% |
| FY2019 | 3.3× | 61.40% |
| FY2018 | 2.1× | 27.00% |
| FY2017 | 1.6× | 43.91% |
| FY2016 | 1.1× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 9.7× | 7.85% |
| Mar 2026 | 9.0× | (4.28%) |
| Dec 2025 | 9.4× | 0.76% |
| Sep 2025 | 9.3× | 8.76% |
| 27 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BNTX BioNTech SE Sponsored ADR compare | 81.8× |
| INCY Incyte Corporation compare | 27.8× |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 26.9× |
| RPRX Royalty Pharma PLC compare | 22.0× |
| RVMD Revolution Medicines, Inc. compare | 11.2× |
| GMAB Genmab A/S Sponsored ADR | 9.7× |
| ROIV Roivant Sciences Ltd. compare | 6.8× |
| INSM Insmed, Inc. compare | 3.3× |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on GMAB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement